Burden in Colombia of COVID-19 in Adults and the Associated Clinical Characteristics: A Retrospective Database Analysis
Studies on the burden of COVID-19 cases in Colombia have focused on specific populations and short timeframes. A retrospective observational study was conducted on adult patients aged 18 diagnosed with COVID-19 who received inpatient and/or outpatient medical care at a large health maintenance organization, to evaluate the burden of COVID-19 cases in Colombia (from March 2020 to January 2023) and associations with demographic and clinical characteristics. COVID-19 cases were identified with ICD-10 codes and confirmed by a laboratory test. The statistical analysis focused on descriptors of the frequency of events. A multivariate regression model was used to identify factors associated with severe conditions and death. Of the 953,661 cases detected, most cases (~79%) were mild or moderate (handled as outpatients). There were 20.1% (N = 191,260) severe cases and 0.9% (N = 8841) critical cases. Most COVID patients were unvaccinated (94.6%) and had, on average, one comorbidity. Hypertension (19.1%), immunocompromised condition (23.8%), mental health conditions (15%), obesity (10.8%), and cancer (11.2%) were the common prevalent comorbidities. The presence of comorbidity increased the risk of severe or critical COVID-19. COVID-19 cases were associated with the lack of vaccination and comorbidities. Effective vaccination strategies are needed to reduce the burden of COVID-19 in Colombia and, considering budgetary constraints, it is advisable to prioritize the elderly or populations with underlying conditions.
Authors
- Omar Escobar
- Farzaneh Maleki (ORCID: https://orcid.org/0000-0002-5119-6619)
- Jhon Edwar Bolaños-López (ORCID: https://orcid.org/0000-0003-1157-5347)
- Jorge La Rotta (ORCID: https://orcid.org/0000-0003-3262-200X)
- Carlos Fernando Mendoza
- Juan Manuel Reyes (ORCID: https://orcid.org/0000-0003-0806-7173)
- Júlia Spinardi (ORCID: https://orcid.org/0000-0002-4324-0317)
- Carlos José Bello-Gándara (ORCID: https://orcid.org/0000-0001-8205-4317)
- Mónica García (ORCID: https://orcid.org/0000-0002-4587-8920)
- Jingyan Yang (ORCID: https://orcid.org/0000-0001-5523-649X)
- Moe H. Kyaw (ORCID: https://orcid.org/0000-0002-0258-6645)
- Lina Jaramillo (ORCID: https://orcid.org/0000-0002-8496-0687)
- Andrea Rubio
- J Arciniegas
- Felipe J. González (ORCID: https://orcid.org/0009-0006-5147-8778)
- Ana Catalina Herrera-Díaz
Institutions
- Pfizer (United States) (US)
- MSD (Mexico) (MX)
Publication Details
- Journal
- Tropical Medicine and Infectious Disease
- Published
- 2025-05-22
- DOI
- https://doi.org/10.3390/tropicalmed10060146
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer